Published in Physician Law Weekly, December 8th, 2004
This is the first new chemotherapy approval for the adjuvant treatment of colon cancer in over a decade, offering patients new hope for potential cure of this disease, one of the nation's deadliest forms of cancer.
"The FDA approval of ELOXATIN in this setting provides...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly